Shanghai No.1 Pharmacy Co., Ltd. (600833.SS)
CNY 14.58
(-4.33%)
CNY 14.58
(-4.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 842.28 Million CNY | -22.04% |
| 2022 | 1.08 Billion CNY | 94.13% |
| 2021 | 556.53 Million CNY | -13.97% |
| 2020 | 646.93 Million CNY | 33.61% |
| 2019 | 484.21 Million CNY | 18.13% |
| 2018 | 409.89 Million CNY | -2.85% |
| 2017 | 421.9 Million CNY | -6.1% |
| 2016 | 449.29 Million CNY | 0.5% |
| 2015 | 447.04 Million CNY | 3.96% |
| 2014 | 430 Million CNY | 13.15% |
| 2013 | 380.02 Million CNY | -3.16% |
| 2012 | 392.42 Million CNY | 7.57% |
| 2011 | 364.79 Million CNY | 3.55% |
| 2010 | 352.29 Million CNY | 10.33% |
| 2009 | 319.31 Million CNY | 16.13% |
| 2008 | 274.95 Million CNY | -9.26% |
| 2007 | 303.02 Million CNY | 28.74% |
| 2006 | 235.38 Million CNY | 112.08% |
| 2005 | 110.98 Million CNY | -50.98% |
| 2004 | 226.39 Million CNY | -23.41% |
| 2003 | 295.58 Million CNY | -2.15% |
| 2002 | 302.07 Million CNY | -4.78% |
| 2001 | 317.23 Million CNY | -63.93% |
| 2000 | 879.39 Million CNY | -14.12% |
| 1999 | 1.02 Billion CNY | 15.46% |
| 1998 | 886.85 Million CNY | 6.81% |
| 1997 | 830.27 Million CNY | -23.07% |
| 1996 | 1.07 Billion CNY | 16.1% |
| 1995 | 929.62 Million CNY | 73.09% |
| 1994 | 537.08 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 809.68 Million CNY | -3.87% |
| 2024 Q2 | 835.45 Million CNY | 3.18% |
| 2024 Q3 | 800.29 Million CNY | -4.21% |
| 2023 Q4 | 842.28 Million CNY | -1.67% |
| 2023 Q1 | 1.09 Billion CNY | 1.4% |
| 2023 FY | 842.28 Million CNY | -22.04% |
| 2023 Q2 | 848.23 Million CNY | -22.58% |
| 2023 Q3 | 856.54 Million CNY | 0.98% |
| 2022 Q4 | 1.08 Billion CNY | -24.17% |
| 2022 FY | 1.08 Billion CNY | 94.13% |
| 2022 Q2 | 1.42 Billion CNY | 174.05% |
| 2022 Q1 | 520.38 Million CNY | -6.5% |
| 2022 Q3 | 1.42 Billion CNY | -0.1% |
| 2021 Q1 | 498.21 Million CNY | -22.99% |
| 2021 FY | 556.53 Million CNY | -13.97% |
| 2021 Q2 | 507.49 Million CNY | 1.86% |
| 2021 Q3 | 505.31 Million CNY | -0.43% |
| 2021 Q4 | 556.53 Million CNY | 10.14% |
| 2020 FY | 646.93 Million CNY | 33.61% |
| 2020 Q1 | 732.67 Million CNY | 51.31% |
| 2020 Q2 | 647.14 Million CNY | -11.67% |
| 2020 Q3 | 638.38 Million CNY | -1.35% |
| 2020 Q4 | 646.93 Million CNY | 1.34% |
| 2019 Q4 | 484.21 Million CNY | 0.42% |
| 2019 FY | 484.21 Million CNY | 18.13% |
| 2019 Q3 | 482.17 Million CNY | 0.57% |
| 2019 Q2 | 479.43 Million CNY | -1.24% |
| 2019 Q1 | 485.45 Million CNY | 18.43% |
| 2018 FY | 409.89 Million CNY | -2.85% |
| 2018 Q1 | 413.23 Million CNY | -2.05% |
| 2018 Q2 | 440.3 Million CNY | 6.55% |
| 2018 Q3 | 437.19 Million CNY | -0.71% |
| 2018 Q4 | 409.89 Million CNY | -6.24% |
| 2017 FY | 421.9 Million CNY | -6.1% |
| 2017 Q2 | 454.58 Million CNY | -3.71% |
| 2017 Q3 | 424.19 Million CNY | -6.69% |
| 2017 Q4 | 421.9 Million CNY | -0.54% |
| 2017 Q1 | 472.07 Million CNY | 5.07% |
| 2016 FY | 449.29 Million CNY | 0.5% |
| 2016 Q4 | 449.29 Million CNY | 5.68% |
| 2016 Q3 | 425.12 Million CNY | 3.28% |
| 2016 Q2 | 411.63 Million CNY | -1.93% |
| 2016 Q1 | 419.72 Million CNY | -6.11% |
| 2015 FY | 447.04 Million CNY | 3.96% |
| 2015 Q4 | 447.04 Million CNY | 2.36% |
| 2015 Q1 | 442.98 Million CNY | 3.02% |
| 2015 Q2 | 443.73 Million CNY | 0.17% |
| 2015 Q3 | 436.74 Million CNY | -1.58% |
| 2014 Q2 | 368.43 Million CNY | -4.35% |
| 2014 Q4 | 430 Million CNY | 9.26% |
| 2014 FY | 430 Million CNY | 13.15% |
| 2014 Q3 | 393.58 Million CNY | 6.82% |
| 2014 Q1 | 385.18 Million CNY | 1.36% |
| 2013 Q2 | 337.96 Million CNY | -10.91% |
| 2013 FY | 380.02 Million CNY | -3.16% |
| 2013 Q3 | 363.23 Million CNY | 7.48% |
| 2013 Q4 | 380.02 Million CNY | 4.62% |
| 2013 Q1 | 379.33 Million CNY | -3.34% |
| 2012 Q1 | 374.12 Million CNY | 2.56% |
| 2012 Q3 | 384.48 Million CNY | 7.09% |
| 2012 Q4 | 392.42 Million CNY | 2.07% |
| 2012 FY | 392.42 Million CNY | 7.57% |
| 2012 Q2 | 359.01 Million CNY | -4.04% |
| 2011 Q2 | 334.61 Million CNY | -7.83% |
| 2011 FY | 364.79 Million CNY | 3.55% |
| 2011 Q1 | 363.03 Million CNY | 3.05% |
| 2011 Q4 | 364.79 Million CNY | 1.37% |
| 2011 Q3 | 359.88 Million CNY | 7.55% |
| 2010 Q1 | 338.72 Million CNY | 6.08% |
| 2010 FY | 352.29 Million CNY | 10.33% |
| 2010 Q4 | 352.29 Million CNY | 1.89% |
| 2010 Q3 | 345.77 Million CNY | 14.94% |
| 2010 Q2 | 300.82 Million CNY | -11.19% |
| 2009 Q1 | 300.74 Million CNY | 9.38% |
| 2009 FY | 319.31 Million CNY | 16.13% |
| 2009 Q4 | 319.31 Million CNY | -5.61% |
| 2009 Q3 | 338.28 Million CNY | 14.63% |
| 2009 Q2 | 295.1 Million CNY | -1.87% |
| 2008 Q4 | 274.95 Million CNY | -4.55% |
| 2008 FY | 274.95 Million CNY | -9.26% |
| 2008 Q1 | 304.78 Million CNY | 0.58% |
| 2008 Q2 | 288.35 Million CNY | -5.39% |
| 2008 Q3 | 288.04 Million CNY | -0.11% |
| 2007 Q3 | 260.68 Million CNY | 12.98% |
| 2007 Q2 | 230.72 Million CNY | -10.05% |
| 2007 Q1 | 256.49 Million CNY | 8.97% |
| 2007 FY | 303.02 Million CNY | 28.74% |
| 2007 Q4 | 303.02 Million CNY | 16.24% |
| 2006 Q1 | 123.54 Million CNY | 11.31% |
| 2006 Q3 | 140.83 Million CNY | 23.07% |
| 2006 FY | 235.38 Million CNY | 112.08% |
| 2006 Q2 | 114.43 Million CNY | -7.37% |
| 2006 Q4 | 235.38 Million CNY | 67.13% |
| 2005 Q4 | 110.98 Million CNY | -52.4% |
| 2005 Q3 | 233.16 Million CNY | 11.73% |
| 2005 Q2 | 208.69 Million CNY | -13.23% |
| 2005 Q1 | 240.5 Million CNY | 6.23% |
| 2005 FY | 110.98 Million CNY | -50.98% |
| 2004 Q4 | 226.39 Million CNY | -14.62% |
| 2004 Q3 | 265.16 Million CNY | -1.43% |
| 2004 Q2 | 269.01 Million CNY | -11.14% |
| 2004 Q1 | 302.73 Million CNY | 2.42% |
| 2004 FY | 226.39 Million CNY | -23.41% |
| 2003 Q3 | 302.97 Million CNY | 5.8% |
| 2003 FY | 295.58 Million CNY | -2.15% |
| 2003 Q1 | 294.12 Million CNY | -2.63% |
| 2003 Q4 | 295.58 Million CNY | -2.44% |
| 2003 Q2 | 286.36 Million CNY | -2.64% |
| 2002 Q1 | 314.97 Million CNY | -0.71% |
| 2002 Q3 | 312.76 Million CNY | 1.98% |
| 2002 FY | 302.07 Million CNY | -4.78% |
| 2002 Q4 | 302.07 Million CNY | -3.42% |
| 2002 Q2 | 306.71 Million CNY | -2.62% |
| 2001 Q2 | 364.72 Million CNY | 0.0% |
| 2001 Q4 | 317.23 Million CNY | -7.01% |
| 2001 Q3 | 341.13 Million CNY | -6.47% |
| 2001 FY | 317.23 Million CNY | -63.93% |
| 2000 Q2 | 1.13 Billion CNY | 0.0% |
| 2000 FY | 879.39 Million CNY | -14.12% |
| 2000 Q4 | 879.39 Million CNY | 0.0% |
| 1999 FY | 1.02 Billion CNY | 15.46% |
| 1999 Q2 | 967.19 Million CNY | 0.0% |
| 1999 Q4 | 1.02 Billion CNY | 0.0% |
| 1998 FY | 886.85 Million CNY | 6.81% |
| 1998 Q2 | 866.38 Million CNY | 0.0% |
| 1998 Q4 | 886.85 Million CNY | 0.0% |
| 1997 Q4 | 830.27 Million CNY | 0.0% |
| 1997 FY | 830.27 Million CNY | -23.07% |
| 1997 Q2 | 748.42 Million CNY | 0.0% |
| 1996 FY | 1.07 Billion CNY | 16.1% |
| 1996 Q4 | 1.07 Billion CNY | 0.0% |
| 1996 Q2 | 658.22 Million CNY | 0.0% |
| 1995 Q2 | 502.81 Million CNY | 0.0% |
| 1995 FY | 929.62 Million CNY | 73.09% |
| 1995 Q4 | 929.62 Million CNY | 0.0% |
| 1994 Q4 | 537.08 Million CNY | 0.0% |
| 1994 FY | 537.08 Million CNY | 0.0% |
| 1994 Q2 | 302.89 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Jointown Pharmaceutical Group Co., Ltd | 63.06 Billion CNY | 98.664% |
| LBX Pharmacy Chain Joint Stock Company | 14.89 Billion CNY | 94.345% |
| Yifeng Pharmacy Chain Co., Ltd. | 13.68 Billion CNY | 93.847% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 7.1 Billion CNY | 88.144% |